Antihypertensive/DM link weakest for ARAs, ACE inhibitors

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1136, 2007-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Cost Effectiveness of ACE Inhibitors as First-Line Antihypertensive Therapy

By Nordmann A.J. Krahn M. Logan A.G. Naglie G. Detsky A.S.

PharmacoEconomics, Vol. 21, Iss. 8, 2003-01 ,pp. : 573-585

Adis International

Access to resources Recommend Favorite

ACE inhibitors dominant for newly diagnosed T2DM

Inpharma, Vol. 1, Iss. 1599, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

ACE inhibitors: Angioedema: case report

Reactions Weekly, Vol. 1, Iss. 1192, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

ACE inhibitors: Angioedema: case report

Reactions Weekly, Vol. 1, Iss. 1160, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Telmisartan TRANSCENDS ACE inhibitors for tolerability

Inpharma, Vol. 1, Iss. 1654, 2008-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite